SCHEDULE 13D

CUSIP No.

0001922335

1

Name of reporting person

Johnson Neil Lawrence

2

Check the appropriate box if a member of a Group (See Instructions)

(a)

(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

Checkbox not checked

6

Citizenship or place of organization

OHIO

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 700,312.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

700,312.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

Checkbox not checked

13

Percent of class represented by amount in Row (11)

6.2 %

14

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13D

Item 1.

Security and Issuer

(a)

Title of Class of Securities:

Class A Common Stock

(b)

Name of Issuer:

Syra Health Corp

(c)

Address of Issuer's Principal Executive Offices:

1119 KEYSTONE WAY N., #201, CARMEL, INDIANA , 46032.

Item 2.

Identity and Background

(a)

Neil Johnson

(b)

88 E Broad St Suite 1750 Columbus OH 43215

(c)

Consulting

(d)

No

(e)

No

(f)

US

Item 3.

Source and Amount of Funds or Other Consideration

Personal Funds

Item 4.

Purpose of Transaction

Influence

Item 5.

Interest in Securities of the Issuer

(a)

700,312 6.2%

(b)

700,312

(c)

Neil Johnson 1/13/2026 38,182 $0.085

(d)

N/A

(e)

N/A

Item 6.

Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer

None

Item 7.

Material to be Filed as Exhibits.

N/A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Johnson Neil Lawrence

Signature:	Neil L Johnson
Name/Title:	Neil Johnson Individual
Date:	01/16/2026